Pharmacare News Bulletins
Nova Scotia Pharmacare
Pharmacare News Bulletins
The Pharmacare News Bulletins, which are mailed to pharmacies and physicians, are listed below. They are an important source of information as they provide timely information on recent changes to the Pharmacare Programs.
Please continue to refer to the Pharmacare News Bulletins to stay current with Formulary and Pharmacare Program updates.
Latest Issues
May Bulletin Vol. 20 – 06
Coverage of Extra Dispensing Fees
April Bulletin Vol. 20 – 05
Coverage of Extra Dispensing Fees
April Bulletin Vol. 20 – 04
Extension of Coverage for Exception Status Medications. New Exception Status Benefits: Ocrevus (ocrelizumab), Fulphila (pegfilgrastim), Lapelga (pegfilgrastim)
March Bulletin Vol. 20 – 03
Public funding for prescription renewal services available effective 19 March 2020. In-person requirement is waived for assessment and prescribing. Adjustment to days supply for dispensing to pharmacare beneficiaries during COVID-19 outbreak.
Latest Issue
April Bulletin Vol. 20 – 03
Extension of Coverage for Exception Status Medications. New Exception Status Benefits: Ocrevus (ocrelizumab), Fulphila (pegfilgrastim), Lapelga (pegfilgrastim)
February Bulletin Vol. 20 – 02
New Exception Status Benefits: Cubicin RF (daptomycin), Duodopa (levodopa/ carbidopa), Glatect (glatiramer acetate), Tygacil (tigecycline), Zerbaxa (ceftolozane/ tazobactam)
January Bulletin Vol. 20 – 01
New Exception Status Benefits: Skyrizi (risankizumab), Probuphine (buprenorphine hydrochloride)
Previous Pharmacists' Bulletins
February Bulletin Vol. 20 – 02 (PDF)
January Bulletin Vol. 20 – 01 (PDF)
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)
Complete Volume Seventeen 2017 (PDF)
Previous Physicians' Bulletins
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)
Complete Volume Seventeen 2017 (PDF)